Cross Country Healthcare, Inc. provided earnings guidance for the second quarter of 2023. For the quarter, the company expected revenue to be in the range of $530 million - $540 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.1 USD | +0.20% | -8.15% | -33.30% |
06/05 | Barrington Cuts Price Target on Cross Country Healthcare to $21 From $24, Maintains Outperform Rating | MT |
01/05 | (CCRN) CROSS COUNTRY HEALTHCARE Sees Q2 EPS Range $0.10 - $0.20 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.30% | 53Cr | |
-11.11% | 973.08Cr | |
-19.11% | 733.78Cr | |
-12.87% | 655.18Cr | |
-1.35% | 373.99Cr | |
-4.63% | 334.99Cr | |
+12.38% | 164.84Cr | |
+11.14% | 151.22Cr | |
-0.83% | 150.3Cr | |
-5.08% | 119.96Cr |
- Stock Market
- Equities
- CCRN Stock
- News Cross Country Healthcare, Inc.
- Cross Country Healthcare, Inc. Provides Earnings Guidance for the Second Quarter of 2023